Insider Selling: Inspire Medical Systems (NASDAQ:INSP) Director Sells $1,655,000.00 in Stock

Inspire Medical Systems (NASDAQ:INSP) Director Marilyn C. Nelson sold 25,000 shares of the business’s stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $66.20, for a total transaction of $1,655,000.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Inspire Medical Systems stock opened at $67.16 on Thursday. The business has a 50-day simple moving average of $58.15. Inspire Medical Systems has a 1 year low of $35.43 and a 1 year high of $69.71.

Inspire Medical Systems (NASDAQ:INSP) last issued its quarterly earnings data on Tuesday, May 7th. The company reported ($0.35) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.39) by $0.04. The firm had revenue of $16.30 million during the quarter, compared to the consensus estimate of $17.79 million. The company’s revenue was up 63.0% on a year-over-year basis.



Several institutional investors and hedge funds have recently made changes to their positions in the company. TD Asset Management Inc. increased its position in shares of Inspire Medical Systems by 3.1% in the first quarter. TD Asset Management Inc. now owns 9,861 shares of the company’s stock worth $560,000 after acquiring an additional 300 shares in the last quarter. Summit Partners Public Asset Management LLC lifted its stake in Inspire Medical Systems by 2.0% in the fourth quarter. Summit Partners Public Asset Management LLC now owns 28,522 shares of the company’s stock valued at $1,205,000 after acquiring an additional 566 shares during the last quarter. FinTrust Capital Advisors LLC acquired a new stake in Inspire Medical Systems in the first quarter valued at approximately $34,000. Capital Financial Planning LLC acquired a new stake in shares of Inspire Medical Systems in the fourth quarter worth $27,000. Finally, Legal & General Group Plc lifted its stake in shares of Inspire Medical Systems by 57.7% in the fourth quarter. Legal & General Group Plc now owns 1,843 shares of the company’s stock worth $78,000 after buying an additional 674 shares during the last quarter.

Several research analysts have weighed in on the stock. Zacks Investment Research lowered shares of Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Saturday, May 11th. Bank of America reissued a “sell” rating on shares of Deutsche Bank in a research note on Monday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $57.20.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Featured Story: What is diluted earnings per share (Diluted EPS)?

Insider Buying and Selling by Quarter for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.